Consistent with the in vitro observations, BBR treatment significantly reduced GPT activity levels in orthotopic tumor tissue, while this effect was reversed in BBR-treated HCC tumor tissue with GPT1 overexpression (Figure 6C). This evidence concerns the gene GPT and hepatocellular carcinoma.